NORTHWEST BIOTHERAPEUTICS IN's ticker is NWBO and the CUSIP is 66737P600. A total of 13 filers reported holding NORTHWEST BIOTHERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | +62.5% | 14,007 | 0.0% | 0.01% | +50.0% |
| Q2 2023 | $8 | -11.1% | 14,007 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $9 | -18.2% | 14,007 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $11 | -99.9% | 14,007 | 0.0% | 0.01% | +20.0% |
| Q3 2022 | $10,000 | +11.1% | 14,007 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $9,000 | -10.0% | 14,007 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 14,007 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $10,000 | -44.4% | 14,007 | 0.0% | 0.00% | -57.1% |
| Q3 2021 | $18,000 | -14.3% | 14,007 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $21,000 | – | 14,007 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 352,660 | $320,815 | 0.06% |
| Opus Capital Group, LLC | 60,150 | $55 | 0.01% |
| AlphaMark Advisors, LLC | 14,007 | $13 | 0.01% |
| ADVISORS MANAGEMENT GROUP INC /ADV | 10,270 | $9 | 0.00% |
| LEE DANNER & BASS INC | 20,000 | $18 | 0.00% |
| Williams Jones Wealth Management, LLC. | 44,000 | $40,027 | 0.00% |
| MAI Capital Management | 20,000 | $18,194 | 0.00% |
| Bartlett & Co. LLC | 4,292 | $4 | 0.00% |
| Coston, McIsaac & Partners | 1,000 | $0 | 0.00% |